FDA Approved: VIGABATRIN — Supplemental Application (Cipla USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin by Cipla USA, Inc., under ANDA211592 (VIGABATRIN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)